83 related articles for article (PubMed ID: 358789)
1. Biochemical and pharmacological studies on dopamine receptors.
Woodruff GN
Adv Biochem Psychopharmacol; 1978; 19():89-118. PubMed ID: 358789
[No Abstract] [Full Text] [Related]
2. Vascular dopamine receptor as a model for other dopamine receptors.
Goldberg LI
Adv Biochem Psychopharmacol; 1978; 19():119-29. PubMed ID: 358776
[No Abstract] [Full Text] [Related]
3. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
[TBL] [Abstract][Full Text] [Related]
4. Structure activity studies on dopamine receptors; a comparison between rat striatal adenylate cyclase and Helix aspersa neurones [proceedings].
Munday KA; Poat JA; Woodruff GN
Br J Pharmacol; 1976 Jul; 57(3):452P-453P. PubMed ID: 974347
[No Abstract] [Full Text] [Related]
5. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
Spano PF; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
[No Abstract] [Full Text] [Related]
6. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
8. The activity of substituted benzamides in biochemical models of dopamine receptors.
Kebabian JW; Tsuruta K; Cote TE; Grewe CW
Adv Biochem Psychopharmacol; 1982; 35():17-49. PubMed ID: 6293277
[No Abstract] [Full Text] [Related]
9. Characteristics of the vascular dopamine receptor: comparison with other receptors.
Goldberg LI; Kohli JD; Kotake AN; Volkman PH
Fed Proc; 1978 Aug; 37(10):2396-402. PubMed ID: 354973
[No Abstract] [Full Text] [Related]
10. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-sensitive adenylyl cyclase: a receptor mechanism for dopamine.
Kebabian JW
Adv Biochem Psychopharmacol; 1978; 19():131-54. PubMed ID: 29445
[No Abstract] [Full Text] [Related]
12. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
13. Adenosine 3',5'-monophosphate in snail (Helix pomatia) nervous system: analysis of dopamine receptors.
Osborne NN
Experientia; 1977 Jul; 33(7):917-9. PubMed ID: 196886
[No Abstract] [Full Text] [Related]
14. Self-inhibitory dopamine-receptors and central effects of apomorphine.
Di Chiara G; Porceddu ML; Morelli M; Gessa GL
Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
[TBL] [Abstract][Full Text] [Related]
15. Dose related sequence of effects induced by the DA agonist 2-(N,N-dipropyl)-amino-5,6-dihydroxytetralin.
Doaré L; Puech AJ; Simon P
J Pharmacol; 1986; 17(1):60-4. PubMed ID: 3713199
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of dopamine "autoreceptors" by microiontophoretic single-cell recording studies.
Aghajanian GK; Bunney BS
Adv Biochem Psychopharmacol; 1977; 16():433-8. PubMed ID: 883551
[No Abstract] [Full Text] [Related]
17. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
18. No evidence for increased dopamine receptor binding in superresponsive mice after a single dose of neuroleptics.
Hyttel J
Adv Biochem Psychopharmacol; 1980; 24():167-73. PubMed ID: 6105773
[No Abstract] [Full Text] [Related]
19. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
Simon P; Charpentier S; Costentin J
Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characteristics of D1 dopamine receptors: relationship to behavior and schizophrenia.
Creese I; Hess EJ
Clin Neuropharmacol; 1986; 9 Suppl 4():14-6. PubMed ID: 2882838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
